These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26108526)

  • 1. Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.
    Klefter ON; Holfort SK; Larsen M
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):467-73. PubMed ID: 26108526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study.
    Klefter ON; Hommel E; Munch IC; Nørgaard K; Madsbad S; Larsen M
    Acta Ophthalmol; 2016 Sep; 94(6):540-7. PubMed ID: 27126300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal function in relation to improved glycaemic control in type 1 diabetes.
    Holfort SK; Nørgaard K; Jackson GR; Hommel E; Madsbad S; Munch IC; Klemp K; Sander B; Larsen M
    Diabetologia; 2011 Jul; 54(7):1853-61. PubMed ID: 21516521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETINAL MICROVASCULOPATHY WITH DIFFERENT INSULIN INFUSION THERAPIES IN CHILDREN WITH TYPE 1 DIABETES MELLITUS WITHOUT CLINICAL DIABETIC RETINOPATHY.
    Guo Y; Zheng X; He H; Zheng S
    Retina; 2024 May; 44(5):895-900. PubMed ID: 38127867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years.
    Clements M; Matuleviciene V; Attvall S; Ekelund M; Pivodic A; Dahlqvist S; Fahlén M; Haraldsson B; Lind M
    Diabetes Technol Ther; 2015 Jan; 17(1):21-8. PubMed ID: 25470010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
    Orr CJ; Hopman W; Yen JL; Houlden RL
    Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of insulin pump therapy in retinal vasculature in type 1 diabetic patients.
    de Oliveira Loureiro T; Cardoso JN; Lopes CDPL; Carreira AR; Rodrigues-Barros S; Vide-Escada A; Campos NP
    Eur J Ophthalmol; 2021 Nov; 31(6):3142-3148. PubMed ID: 33499670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
    Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
    J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes.
    Nabhan ZM; Kreher NC; Greene DM; Eugster EA; Kronenberger W; DiMeglio LA
    Pediatr Diabetes; 2009 May; 10(3):202-8. PubMed ID: 19140899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.
    Mameli C; Scaramuzza AE; Ho J; Cardona-Hernandez R; Suarez-Ortega L; Zuccotti GV
    Acta Diabetol; 2014 Apr; 51(2):205-10. PubMed ID: 23681558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Ophthalmology; 1988 Oct; 95(10):1358-66. PubMed ID: 3067179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.
    Retnakaran R; Hochman J; DeVries JH; Hanaire-Broutin H; Heine RJ; Melki V; Zinman B
    Diabetes Care; 2004 Nov; 27(11):2590-6. PubMed ID: 15504991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.